Trials / Completed
CompletedNCT02158325
Capsulorhexis Size and Capsular Outcome
Appropriate Capsulorhexis Size Results in Better Capsular Outcome When Treating Pediatric Cataract: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
Different capsulorhexis size results in different capsular outcome when treating pediatric cataract, and there should be an appropriate capsulorhexis size for the best capsular outcome.
Detailed description
Numerous studies have reported that ideal anterior capsulorhexis size is 4.5-5.0 mm with the capsulorhexis edges covering IOL optic surface because it can inhibit the proliferation and migration of remnant lens epithelial cells (LEC). But there are no reports investigating the relationship between the capsulorhexis size and the capsular outcome after pediatric cataract surgery. Therefore, the aim of the current study is to prospective evaluate the capsular outcomes of three controlled groups receiving different anterior capsulorhexis sizes (3.0-3.9, 4.0-5.0, 5.1-6.0 mm in diameter).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | anterior capsulorhexis sizes | Pediatric cataract surgery performed with different anterior capsulorhexis sizes (3.0\~3.9, 4.0\~5.0, 5.1\~6.0 mm in diameter) |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2014-06-06
- Last updated
- 2014-06-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02158325. Inclusion in this directory is not an endorsement.